Increased OS in the placenta has been linked to the release of anti-angiogenic proteins such as endoglin and soluble fms-like tyrosine kinase-1 (sFlt-1), which are known to disrupt normal endothelial function and cause proteinuria and hypertension [19,20,21]. The gene discussed is FLT1; the disease is hypertensive disorder.